SG11201710583RA - Ameliorating agent for detrusor hyperactivity with impaired contractility - Google Patents

Ameliorating agent for detrusor hyperactivity with impaired contractility

Info

Publication number
SG11201710583RA
SG11201710583RA SG11201710583RA SG11201710583RA SG11201710583RA SG 11201710583R A SG11201710583R A SG 11201710583RA SG 11201710583R A SG11201710583R A SG 11201710583RA SG 11201710583R A SG11201710583R A SG 11201710583RA SG 11201710583R A SG11201710583R A SG 11201710583RA
Authority
SG
Singapore
Prior art keywords
ameliorating agent
detrusor hyperactivity
impaired contractility
contractility
impaired
Prior art date
Application number
SG11201710583RA
Inventor
Yukio Hayashi
Takahisa Noma
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of SG11201710583RA publication Critical patent/SG11201710583RA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11201710583RA 2015-08-04 2016-08-03 Ameliorating agent for detrusor hyperactivity with impaired contractility SG11201710583RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/817,318 US20170035705A1 (en) 2015-08-04 2015-08-04 Detrusor hyperactivity with impaired contractility ameliorating agent
PCT/JP2016/072753 WO2017022787A1 (en) 2015-08-04 2016-08-03 Ameliorating agent for detrusor hyperactivity with impaired contractility

Publications (1)

Publication Number Publication Date
SG11201710583RA true SG11201710583RA (en) 2018-01-30

Family

ID=57943093

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201710583RA SG11201710583RA (en) 2015-08-04 2016-08-03 Ameliorating agent for detrusor hyperactivity with impaired contractility

Country Status (17)

Country Link
US (3) US20170035705A1 (en)
EP (1) EP3332779B1 (en)
JP (1) JP6328856B2 (en)
KR (2) KR102076137B1 (en)
CN (1) CN107921011A (en)
AU (1) AU2016301689B2 (en)
BR (1) BR112017028381A2 (en)
CA (1) CA2994648C (en)
ES (1) ES2836685T3 (en)
HK (1) HK1247106A1 (en)
MX (1) MX2018001518A (en)
MY (1) MY197287A (en)
PH (1) PH12018500176A1 (en)
RU (1) RU2714444C2 (en)
SG (1) SG11201710583RA (en)
TW (1) TWI668005B (en)
WO (1) WO2017022787A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6894555B1 (en) * 2020-07-03 2021-06-30 大鵬薬品工業株式会社 Urinary symptom therapeutic agent
JP2022013721A (en) * 2020-07-03 2022-01-18 大鵬薬品工業株式会社 Urinary symptom therapeutic agent

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1003706B1 (en) 1997-08-13 2003-03-05 Meiji Milk Products Company Limited Cyclohexenone long-chain alcohol and medicament containing same
JP3836684B2 (en) 2001-02-19 2006-10-25 明治乳業株式会社 Treatment for dysuria
RU2193401C1 (en) * 2001-04-02 2002-11-27 Аль-Шукри Салман Хасунович Method for treating hyperactivity of urinary bladder
EP1767208A4 (en) * 2004-07-05 2007-12-05 Chugai Pharmaceutical Co Ltd Remedy for hyperactive bladder
JPWO2006077853A1 (en) * 2005-01-18 2008-06-19 明治乳業株式会社 Sensory disorder treatment
JP2009292797A (en) * 2008-06-09 2009-12-17 Kyoto Univ Therapeutic agent for overactive bladder
JP2015067565A (en) 2013-09-27 2015-04-13 大鵬薬品工業株式会社 Pharmaceutical composition containing 3-(15-hydroxypentadecyl)-2,4,4-trimethyl-2-cyclohexene-1-on or salt thereof
JP5566521B1 (en) 2013-09-27 2014-08-06 大鵬薬品工業株式会社 Bladder / urethral coordination disorder improving agent

Also Published As

Publication number Publication date
HK1247106A1 (en) 2018-09-21
KR20190134825A (en) 2019-12-04
MX2018001518A (en) 2018-04-24
RU2018107515A3 (en) 2019-09-05
US20170252307A1 (en) 2017-09-07
TW201717924A (en) 2017-06-01
PH12018500176A1 (en) 2018-07-30
RU2018107515A (en) 2019-09-05
EP3332779B1 (en) 2020-10-28
RU2714444C2 (en) 2020-02-17
KR102076137B1 (en) 2020-02-11
EP3332779A4 (en) 2019-03-13
BR112017028381A2 (en) 2018-08-28
AU2016301689A1 (en) 2018-01-25
CA2994648A1 (en) 2017-02-09
TWI668005B (en) 2019-08-11
EP3332779A1 (en) 2018-06-13
US20170035706A1 (en) 2017-02-09
MY197287A (en) 2023-06-09
JP6328856B2 (en) 2018-05-23
US9687457B2 (en) 2017-06-27
WO2017022787A1 (en) 2017-02-09
CA2994648C (en) 2020-04-07
CN107921011A (en) 2018-04-17
ES2836685T3 (en) 2021-06-28
KR20180038003A (en) 2018-04-13
AU2016301689B2 (en) 2018-10-04
US20170035705A1 (en) 2017-02-09
JPWO2017022787A1 (en) 2018-04-26

Similar Documents

Publication Publication Date Title
HK1246825A1 (en) Cell
HK1252162A1 (en) Cell
HK1250667A1 (en) Cell
GB201507368D0 (en) Cell
GB201503500D0 (en) Cell
HK1258690A1 (en) Food-improving agent
HRP20180568T1 (en) Rolling gate
HK1231388A1 (en) Glucose metabolism ameliorating agent
GB201500584D0 (en) Cancer biomarkers
GB2536251B (en) Recirculation valve
HK1247106A1 (en) Ameliorating agent for detrusor hyperactivity with impaired contractility
GB201719541D0 (en) Cell Lines
GB201602626D0 (en) Glycemic reducing composition
PL3085867T3 (en) Gate
PL3064698T3 (en) Gate
GB201512133D0 (en) Biomarkers
HK1218736A1 (en) Infinite-connection energy-saving pencil
HK1259489A1 (en) Proenzyme composition
IL259259B1 (en) Proenzyme composition
PL3156578T3 (en) Sectional gate
HK1216062A2 (en) Laptop bearing
GB201519704D0 (en) Biomarkers
AU366960S (en) Chalkboard
GB2535541B (en) Envelope with Fold-Under Region
GB201513683D0 (en) Biomarkers